Table 4.

Effect of PLN and LNPR risk stratification on cervical recurrence types of stage T1 papillary thyroid carcinoma.

Recurrence	Variables	Unadjusted		Adjusted a
type		OR (95%CI)	P	OR (95%CI)	P
RT
	HPLN vs. LPLN	0.63(0.20-1.69)	0.388	1.75(0.64-5.54)	0.299
LN
	HPLN vs. LPLN	0.25(0.12-0.52)	<0.001	0.27(0.12-0.55)	<0.001
RT+LN
	HPLN vs. LPLN	0.10(0.03-0.25)	<0.001	0.10(0.03-27.00)	<0.001
RT
	HLNPR vs. LLNPR	1.42(0.49-3.69)	0.489	0.70(0.27-2.07)	0.492
LN
	HLNPR vs. LLNPR	0.19(0.09-0.39)	<0.001	0.19(0.09-0.40)	<0.001
RT+LN
	HLNPR vs. LLNPR	0.16(0.07-0.34)	<0.001	0.17(0.07-37.30)	<0.001

RT, residual thyroid; LN, lymph node; HPLN, high positive lymph node; LPLN, low positive lymph node; HLNPR, high lymph node positive ratio; LLNPR, low lymph node positive ratio;

^aAdjusted for gender, age, T stage, Capsular invasion, Hashimoto thyroiditis and Multifocal.